Gujarat Inject (Kerala) Share Price
Small Cap | Pharmaceuticals and health care | BSE: 524238
₹27.87 
1.06 (3.95 %)
Last Updated: 13 Mar 2025 12:00 AM
BEARISH
Overview
Open (₹) 26.05
High (₹) 27.99
Low (₹) 25.95
Prev. Close (₹) 26.81
Volume 13,807
VWAP (₹) 27.24
ROCE (%) 1.23
Industry P/E 43.95
TTM P/E 41.60
P/B Ratio 3.68
Market Cap (₹) Cr.40.83
Dividend Yield (%)--
EPS (₹) 0.09
ROE1.19%
Sales Growth (%) 3231.11
Profit Growth (%)101.63
Day Range
27.9927.99
52 Week Range
8.7429.00
Historical Returns
Returns (6M)
49.92 %
Returns (1Y)
139.23 %
Returns (3Y)
1046.91 %
Returns (5Y)
1046.91 %
Returns (6M)
49.92 %
Returns (1Y)
139.23 %
Returns (3Y)
1046.91 %
Returns (5Y)
1046.91 %
SWOT Analysis
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- Positive ROC (9) indicates upward momentum.
- Price above the pivot point indicates bullish sentiment.
- Price above EMA and SMA (50) indicates bullish momentum.
Technicals
Technical Rating
BEARISHRSI 38.40
MFI 56.43
ATR 1.71
Commodity Channel Index 46.55
ROC125 94.24
ROC21 7.63
Williams %R -33.25
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 28.33 | 29.00 | 30.16 | 27.17 | 26.50 | 25.34 | 24.67 |
| Week Ago | 28.83 | 29.46 | 30.27 | 28.02 | 27.39 | 26.58 | 25.95 |
| Month Ago | 27.06 | 28.18 | 28.96 | 26.28 | 25.16 | 24.38 | 23.26 |
EMA & SMA
27.87
Current Price
Bullish Moving Averages
20
Bearish Moving Averages
0
5 Day 27.65
9 Day 27.13
10 Day 26.98
12 Day 27.08
14 Day 27.26
20 Day 26.55
26 Day 26.52
50 Day 25.72
100 Day 21.06
200 Day 15.94
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| KAMLABA JAGATSINH RATHOD | bulk | Sell | 12 Mar, 2025 | ₹24.68 | 1,00,000 | BSE |
| PATEL SHIVLAL KUBERBHAI | bulk | Sell | 17 Jan, 2025 | ₹25.02 | 1,28,000 | BSE |
| RAJESH SHANTILAL SANGHVI | bulk | Sell | 27 Dec, 2024 | ₹22.29 | 3,91,000 | BSE |
| KRISHNA KUMAR GOYAL | bulk | Buy | 27 Dec, 2024 | ₹22.28 | 1,00,000 | BSE |
| VIVEK KANDA | bulk | Sell | 23 Apr, 2024 | ₹14.18 | 30,000 | BSE |
| SATISH PURUSHOTTAM PASEBAND | bulk | Buy | 23 Apr, 2024 | ₹14.17 | 26,129 | BSE |
| LAKSHMI NARAYANAMMA POLINENI | bulk | Sell | 09 Apr, 2024 | ₹9.62 | 30,500 | BSE |
| RUCHIRA GOYAL | bulk | Buy | 09 Apr, 2024 | ₹9.62 | 25,000 | BSE |
| ANKITABEN INDRAVADANBHAI PARMAR | bulk | Sell | 21 Dec, 2023 | ₹11.52 | 25,976 | BSE |
| RUCHIRA GOYAL | bulk | Buy | 21 Dec, 2023 | ₹11.52 | 30,000 | BSE |
Insider Trading
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 18 Feb, 2025 | Stock split from Rs. 10/- to Re. 1/-. | 01 Jan, 1970 | 01 Jan, 1970 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 12 Mar, 2025 | BSE India | EGM TO BE HELD ON 03.04.2025 |
| 18 Feb, 2025 | BSE India | Outcome of the Board Meeting held on Tuesday 18th February, 2025 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation. 2015 |
| 13 Feb, 2025 | BSE India | GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/02/2025 ,inter alia, to consider and approve proposal for sub- division/split of the equity shares of the Company, in such manner, as may be determined by the Board of Directors and subject to approval of the Shareholders and such authorities, as may be required |
| 05 Feb, 2025 | BSE India | Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company, at its meeting held today i.e., Wednesday, 5th February, 2025, could not come to conclusion on the subject matter of Stock Split/sub-division of the equity shares of the company due to some technical and unavoidable circumstances. |
| 01 Feb, 2025 | BSE India | GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 ,inter alia, to consider and approve proposal for sub- division/split of the equity shares of the Company, in such manner, as may be determined by the Board of Directors and subject to approval of the Shareholders and such authorities, as may be required |
| 23 Jan, 2025 | BSE India | Unaudited Financial Results of the Company for the quarter and nine months ended on December 31, 2024 along with Limited Review Report (Unmodified Opinion) |
| 23 Jan, 2025 | BSE India | In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on January 23, 2025, at the Registered Office of the Company which was commenced at 05:00 P.M. and concluded at 05:20 P.M., have, apart from other businesses, \r\n\r\n1) Considered, approved and taken on record the Unaudited Financial Results of the Company for the quarter and nine months ended on December 31, 2024 along with Limited Review Report (Unmodified Opinion) In this regards, we are hereby submitting the followings: \r\n\r\n1. Unaudited Financial Results for the quarter and nine months ended on December 31, 2024;\r\n2. Limited review report;\r\n\r\nKindly take the same on your record and oblige us. |
| 17 Jan, 2025 | BSE India | Certificate under Regulation 74(5) of SEBI(Depositories and Participants) Regulation, 2018 for the quarter ender December 31, 2024 |
| 22 Oct, 2024 | BSE India | Unaudited Financial Result of the Company for the quarter and half year ended on September 30, 2024 along with Limited Review Report (Unmodified Opinion) |
| 22 Oct, 2024 | BSE India | In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on October 22, 2024, at the Registered Office of the Company which was commenced at 04:00 P.M. and concluded at 04:40 P.M., have, apart from other businesses, \r\n\r\n1) Considered, approved and taken on record the Unaudited Financial Results of the Company for the quarter and half year ended on September 30, 2024 along with Limited Review Report (Unmodified Opinion) In this regards, we are hereby submitting the followings: \r\n\r\n1. Unaudited Financial Results for the quarter and half year ended on September 30, 2024;\r\n2. Limited review report; |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Stock Split | -- | 18 Feb, 2025 | 18 Feb, 2025 |
| Quarterly Results | -- | 21 Jan, 2025 | 23 Jan, 2025 |
| Quarterly Results | -- | 08 Oct, 2024 | 22 Oct, 2024 |
| Quarterly Results | -- | 05 Aug, 2024 | 10 Aug, 2024 |
| Audited Results | -- | 07 May, 2024 | 09 May, 2024 |
| Quarterly Results | -- | 06 Feb, 2024 | 13 Feb, 2024 |
| Others | Inter alia, (1) To discuss and consider acceptance of unsecured Loans with an option of conversion into equity shares of Gujarat Inject Kerala Limited. | 18 Nov, 2023 | 22 Nov, 2023 |
| Quarterly Results | -- | 04 Nov, 2023 | 06 Nov, 2023 |
| Quarterly Results & Preferential issue | -- | 27 Oct, 2023 | 03 Nov, 2023 |
| Quarterly Results | -- | 17 Aug, 2023 | 14 Aug, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Apr, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Gujarat Inject (Kerala)
Gujarat Inject (Kerala) is a Public Limited Listed company incorporated on 07/01/1991 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L46309GJ1991PLC151872 and registration number is 151872. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 5.79 Cr. and Equity Capital is Rs. 11.29 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1991
Managing Director
-- --
NSE Symbol
--
Gujarat Inject (Kerala) Management
| Name | Designation |
|---|---|
| Mr. Murli Nair | Whole Time Director |
| Ms. Reena Mahatma | Non Executive Director |
| Mr. Gautam Chauhan | Independent Director |
| Mr. Narayansinh Chauhan | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45  ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45  ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
| Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on Gujarat Inject (Kerala)
What is the share price of Gujarat Inject (Kerala)?
The share price of Gujarat Inject (Kerala) on 13 Mar, 2025 is ₹ 27.87.
What is 52W high and 52W low share price of Gujarat Inject (Kerala)?
The highest and lowest 52W share prices of Gujarat Inject (Kerala) are ₹ 29.000 and ₹ 8.740
What is the market cap of Gujarat Inject (Kerala)?
The market capitalization of Gujarat Inject (Kerala) as of 13 Mar, 2025 is ₹ 40.83 Crores
What is the P/E ratio of Gujarat Inject (Kerala)?
The current P/E ratio of Gujarat Inject (Kerala) as of 13 Mar, 2025 is 43.95
What is the PB ratio of Gujarat Inject (Kerala)?
The PB ratio of Gujarat Inject (Kerala) as of 13 Mar, 2025 is 3.68
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)